The big idea: When major research findings are shared openly, discoveries happen faster and reach farther than any single lab could achieve alone.
What’s happening: University of Utah Health is committing to make all data from its $21.6 million NIH study on blood pressure and dementia publicly available once analysis is complete in early 2027.
- The study involves nearly 40,000 blood samples from the landmark SPRINT trial, measuring biomarkers that reveal how hypertension interacts with both vascular brain health and Alzheimer’s pathology.
- Dr. Adam Bress and his team are partnering with Banner Alzheimer’s Institute to analyze the samples over the next two years.
Why it matters: Open data accelerates scientific progress in ways that benefit everyone.
- Students in Dr. Bress’s lab and his collaborators’ labs will work directly on the project from beginning to end, gaining hands-on research experience.
- Once publicly available, students and researchers from across the world will be able to use this data for dissertations, new studies, and follow-up discoveries without waiting years for secondary publications.
- It multiplies the number of scientists working on the same problem, increasing the speed and volume of breakthroughs.
- Publicly funded research should serve the public, and open data ensures taxpayer investments deliver maximum return.
The bottom line: Invest in discovery. Share the findings. Let the next generation build on what you learned.